Get started
Author

Rachel E. Powell

BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90
2009 · Karen Lundgren, Hong Zhang, et al. · Molecular Cancer Therapeutics · 173
PDF
Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor
2011 · Fedik Rahimov, Oliver D. King, et al. · Physiological Genomics · 56
Association Between Preexisting Heart Failure With Reduced Ejection Fraction and Fluid Administration Among Patients With Sepsis
2022 · Rachel E. Powell, Jason N. Kennedy, et al. · JAMA Network Open · 16
What’s new in intensive care: disease tolerance
2023 · Rachel E. Powell, Miguel P. Soares, et al. · Intensive Care Medicine · 11
PDF
Circulating hypoxia-dependent miR-210 is increased in clinical sepsis subtypes: A cohort study
2022 · Rachel E Powell, Yi Yin Tai, et al. · Journal of Translational Medicine · 9
PDF
Measuring signatures of host resistance, disease tolerance, and damage in human sepsis: a prospective cohort study
2026 · Arnab Chowdhury, Rachel E. Powell, et al. · Intensive Care Medicine · 5
PDF
The association between prehospital HMGB1 and sepsis in emergency care
2022 · Stuthi Iyer, Jason N. Kennedy, et al. · European Journal of Emergency Medicine · 3
A Prospective Cohort Protocol for the Remnant Investigation in Sepsis Study
2023 · Christopher W. Seymour, Kelly Lynn Urbanek, et al. · Critical Care Explorations · 2
Symptomatic Methemoglobinemia at Low Levels in a Patient With Obstructive Sleep Apnea
2026 · Don Mathew, Rachel E. Powell · Annals of Internal Medicine Clinical Cases
muscle dysfunction receptor/Fc fusion protein improves hypoxia-induced Pretreatment with a soluble activin type IIB
2011 · Tejvir S. Khurana, Emidio E. Pistilli, et al.
Works count: 10
Citation count: 275
H-index: 5
I10-index: 4
Year
Topic
Type